Pfizer的例句大全

Lipitor, a cholesterol drug that earned Pfizer about$ 12 billion last year, loses patent protection in America in2011;

2011年，辉瑞的降胆固醇药立普妥（Lipitor）在美国的专利保护协议将到期，立普妥在去年为辉瑞挣得了120亿美元；

Lipitor, the world's best-selling drug at$ 13 billion a year, accounts for a fourth of Pfizer's revenue.

立普妥，世界上卖得最好的药物，年销售额130亿美元，占辉瑞收入的四分之一。

Patent infringement litigation between Pfizer and Ranbaxy over Lipitor will continue in Finland, Spain, Portugal, Denmark and Romania.

专利侵权诉讼之间的辉瑞和兰伯西超过立普妥将继续在芬兰，西班牙，葡萄牙，丹麦和罗马尼亚。

But he wants in the Lipitor patent expires, to avoid Pfizer's sales plummeted, I am afraid, will have to do more.

但他若想在立普妥专利到期后，避免辉瑞的销售额直线下滑，恐怕还得做更多的工作。

While Pfizer ( PFE) is seeing reduced economic value in reinvesting in its cholesterol franchise ( Lipitor), AstraZeneca appears to be pumping as much air in the cholesterol bubble as it can muster.

虽然辉瑞投资立普妥的经济价值在减少，而阿斯利康投资胆固醇药物的计划却方兴未艾，试图给胆固醇泡沫充入更多的空气。

Pfizer spokesman said Thursday the company is awaiting a letter from the patent office explaining the decision.

辉瑞发言人说周四公司等待着专利局的对这一裁决的解释信。

This review follows Pfizer's voluntary withdrawal of the marketing authorisation of its celecoxib-containing orphan medicine, Onsenal, which had been authorised for use in FAP patients.

这次审评是在辉瑞公司自愿撤回含塞来昔布成分孤儿药Onsenal的销售许可后进行的。

Professor Toby Peters of the University of Birmingham says ultra-cold temperatures required by the Pfizer-Biontech vaccine will pose a challenge for many countries.

伯明翰大学的托比·彼得斯教授表示，辉瑞和生物新技术公司共同开发疫苗所需的超低温将对许多国家构成挑战。

Pfizer has been working to become the bio-technology and oncology an important one, Amgen will enable them to achieve the set target.

辉瑞一直在致力于成为生物科技和肿瘤学领域的重要一员，安进将会助其实现既定目标。

since pfizer corporation of america set up the first manager stock option, the enterprises in western developed countries such as american have widely adopted this mechanism.

自从1952年美国Pfizer公司推出第一个经理股票期权以来，美国等西方发达国家的企业开始普遍采用股票期权制。

while avelumab is designed to remove the brakes in the immune system, pfizer thinks the other two drugs will speed up the body's response, likening their effects to the "gas" or "oil" needed to run a well-functioning engine.

Avelumab旨在移除免疫系统中的“制动器”，辉瑞认为，另两种药物将加快人体的反应，它把它们的效果比作让一个功能良好的引擎运转所需的“气”或“油”。

Pfizer's patent on Viagra expired in China in May, following patent expirations in several European countries and elsewhere that are expected to undercut profits for the American pharmaceutical giant as cheaper alternatives are rolled out.

辉瑞公司的万艾可专利已于五月在中国到期，公司在几个欧洲国家和其他地区的专利此前也已陆续到期，预计随着便宜替代品的推出，这个美国制药业巨头的利润将受到侵蚀。

Viagra was introduced to China in 1998, but Pfizer faced a range of challenges to its patent and other litigation until 2007.

万艾可在1998年进入中国市场，辉瑞曾面临过从专利到其他诉讼等一系列挑战，直至2007年。

A Chinese pharmaceutical company has received the green light from China's State Food and Drug Administration to become the country's first official producer of a homegrown version of Viagra, Pfizer's famous erectile dysfunction drug.

一家中国制药公司已得到国家食品药品监督管理局批准，成为国内首家正式生产国产版本万艾可（Viagra）的厂家，万艾可是辉瑞公司（Pfizer）治疗勃起功能障碍的著名药物。

Foreign companies such as Roche Holding AG ROG.VX+ 0.06% and Pfizer Inc. PFE+ 1.51% also have invested heavily in the country over the past few years.

罗氏公司（Roche Holding AG）和辉瑞制药有限公司（Pfizer Inc.）等外国企业过去几年也在中国大举投资。

Professor Coffey is planning a clinical trial of a stem cell treatment for macular degeneration, an important cause of blindness, in partnership with Pfizer, the giant US drug company.

科菲教授计划与美国医药公司巨头辉瑞公司（pfizer）合作，对黄斑退化症进行干细胞治疗的临床试验。

A year and a half ago, Pfizer Inc. ( PFE) got a disturbing call on its customer hotline.

一年半前，辉瑞制药（PFE）接到一个令人不安的呼吁其客户热线。

Steve Yang, the company's chief operating officer and a veteran of AstraZeneca, Pfizer and the University of California, urges caution.

但该公司首席运营官杨青（Steve Yang）呼吁保持谨慎。杨青毕业于加州大学（University of California），曾在阿斯利康、辉瑞担任高管。

The experts from Imperial College London and the drug giant Pfizer report their findings in Proceedings of the National Academy of Sciences.

来自伦敦皇家学院和制药巨头辉瑞的专家们在国家科学院的学报上报道了他们的发现。

Other major drug companies with a research presence in China include Novartis AG, AstraZeneca Plc, Pfizer Inc., GlaxoSmithKline and Roche Holding AG.

在中国开展药物研究的其他主要制药公司包括诺华，阿斯利康，辉瑞，葛兰素史克和罗氏。